I'm LongbridgeAI, I can summarize articles.Bambusa Therapeutics (BBTX.US) climbed more than 3% during regular trading to $15.46.
The company completed an oversubscribed initial public offering on Oct. 30 at $16 per share, raising $169 million.
Based on public media reports. AI-generated; not investment advice.
